A transition plan developed for the ENGAGE-AF TIMI 48 trial was associated with reduced excess thrombotic and bleeding events in patients moved from one oral anticoagulant to another. In the ...

The anticoagulation management system should be designed to ensure appropriate care transitions for patients receiving anticoagulant therapy. The health care system in the US has a fragmented ...

"This device often permits patients at high risk of GI bleeding to transition off anticoagulant and antiplatelet drugs." Clin Gastroenterol Hepatol . Published online August 13, 2022. doi:10.1016 ...